14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

Acorda Therapeutics Stock Forecast

NASDAQ:ACOR BUY SELL

$0.55 (-4.25%)

Volume: 359.188k

Closed: May 19, 2022

Hollow Logo Score: -6.865

Acorda Therapeutics Stock Forecast

BUY SELL NASDAQ:ACOR
$0.55 (-4.25%)

Volume: 359.188k

Closed: May 19, 2022

Score Hollow Logo -6.865

Acorda Therapeutics Stock Forecast NASDAQ:ACOR

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2021-06-17 1718.18% HC Wainwright & Co. $5.00 $10.00 Upgrades Neutral Buy
2020-05-06 809.09% HC Wainwright & Co. $6.00 $5.00 Reiterates Neutral
2019-10-24 - JP Morgan - Downgrades Neutral Underweight
2019-08-14 990.91% HC Wainwright & Co. $31.00 $6.00 Downgrades Buy Neutral
2019-08-02 1172.73% Stifel $12.00 $7.00 Maintains Hold
2019-08-02 1172.73% Wedbush $8.00 $7.00 Reiterates Neutral
2019-05-23 2081.82% Wedbush $12.00 Initiates Coverage On Neutral

ACOR Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.53 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -56.64% during the next 3 months and, with a 90% probability hold a price between $0.23 and $0.47 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-23 $0.51 $0.79 $1.06
2022-05-24 $0.49 $0.76 $1.04
2022-05-25 $0.46 $0.74 $1.02
2022-05-26 $0.44 $0.72 $0.99
2022-05-27 $0.42 $0.69 $0.97
2022-05-31 $0.39 $0.67 $0.95
2022-06-01 $0.37 $0.65 $0.92
2022-06-02 $0.35 $0.62 $0.90
2022-06-03 $0.32 $0.60 $0.88
2022-06-06 $0.30 $0.58 $0.85
2022-06-07 $0.28 $0.55 $0.83
2022-06-08 $0.25 $0.53 $0.81
2022-06-09 $0.23 $0.51 $0.78
2022-06-10 $0.21 $0.48 $0.76
2022-06-13 $0.18 $0.46 $0.74
2022-06-14 $0.16 $0.44 $0.71
2022-06-15 $0.14 $0.41 $0.69
2022-06-16 $0.11 $0.39 $0.67
2022-06-17 $0.0913 $0.37 $0.64
2022-06-21 $0.0681 $0.34 $0.62
2022-06-22 $0.0448 $0.32 $0.60
2022-06-23 $0.0215 $0.30 $0.57
2022-06-24 $-0.0017 $0.27 $0.55
2022-06-27 $-0.0250 $0.25 $0.53
2022-06-28 $-0.0483 $0.23 $0.50
2022-06-29 $-0.0715 $0.21 $0.48
2022-06-30 $-0.0948 $0.18 $0.46
2022-07-01 $-0.12 $0.16 $0.44
2022-07-05 $-0.14 $0.14 $0.41
2022-07-06 $-0.16 $0.11 $0.39

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT